Skip to main content

Table 3 Ranges of susceptibility against penicillin-susceptible (≤0.06 mg/l), penicillin-intermediate and penicillin-resistant (≥2 mg/l) pneumococcal isolates, calculated with MIC distributions from published studies [41,42,43,44,45] by applying CLSI breakpoints (amoxicillin, cefuroxime) and the three proposed breakpoints for cefditoren

From: Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults

Antibiotic

Penicillin susceptible isolates

Penicillin intermediate isolates

Penicillin resistant isolates

Amoxicillina (≤2 mg/l)

100%

78.4–100%

17.5–76%

Cefuroxime (≤1 mg/l)

99.7–100%

33.8–67.6%

0–0.4%

Cefditoren

  ≤ 0.125 mg/l

99.1–100%

37.2–71.2%

0–0.4%

  ≤ 0.25 mg/l

100%

67.6–88.6%

15.2–57.3%

  ≤ 0.5 mg/l

100%

99.3–100%

95.3–100%

  1. aAmoxicillin/clavulanic acid in references [41, 42]